Heat Biologics eyes Zika vaccine | Chemical & Engineering News
Volume 94 Issue 43 | p. 13 | Concentrates
Issue Date: October 31, 2016

Heat Biologics eyes Zika vaccine

Department: Business
Keywords: vaccines, immunotherapy, University of Miami

Heat Biologics has licensed patents from the University of Miami that it will use to develop vaccines against the Zika virus. The Zika program will be directed by Natasa Strbo, a reproductive immunologist at Miami who codeveloped Heat’s gp96-based immunotherapy technology. Heat Biologics currently uses the technology to create therapeutic cancer vaccines. The new Zika vaccines will be developed by a just-formed Heat subsidiary, Zolovax.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment